Literature DB >> 27579591

Toxoplasmosis in Nigeria: the story so far (1950-2016): a review.

John Asekhaen Ohiolei1, Clement Isaac1.   

Abstract

Toxoplasmosis is caused by intracellular protozoan parasite, Toxoplasma gondii (Nicolle et Manceaux, 1908). Cats and other felids are the definitive hosts. It could be transmitted to man and animals by consumption of infected undercooked meat and contaminated food items including drinking water. Results of toxoplasmosis epidemiological surveys in animals and humans in South-West, North-West, North-East and North-Central Zones of Nigeria have been reported with greater impact on the health of pregnant women and HIV-infected individuals. Meanwhile, studies in states within the South-South and South-East Zones are relatively scanty or non-existent. Overall, the seroprevalence of human toxoplasmosis in Nigeria is estimated at 32% with the following reports for North-West (32%), North-East (22%), North-Central (24%) and South-West (37%). Information on the genetic diversity of isolates of T. gondii in humans and animals including the role of the environment in transmission and maintenance of the disease are highly needed.

Entities:  

Keywords:  Nigeria; Toxoplasma gondii; animals; environment; humans; seroprevalence

Mesh:

Substances:

Year:  2016        PMID: 27579591     DOI: 10.14411/fp.2016.030

Source DB:  PubMed          Journal:  Folia Parasitol (Praha)        ISSN: 0015-5683            Impact factor:   2.122


  2 in total

1.  Toxoplasmosis - Awareness and knowledge among medical doctors in Nigeria.

Authors:  Akinwale Michael Efunshile; Charles John Elikwu; Pikka Jokelainen
Journal:  PLoS One       Date:  2017-12-19       Impact factor: 3.240

2.  Evaluation of the level of awareness of congenital toxoplasmosis and associated practices among pregnant women and health workers in Tanzania's Temeke district in Dar es Salaam.

Authors:  Onduru Gervas Onduru; Susan Fred Rumisha; Musso Munyeme; Andrew Malata Phiri
Journal:  Afr Health Sci       Date:  2019-12       Impact factor: 0.927

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.